Manitoba man won't lose access to drug slowing degenerative disease's progression after federal shift

A Manitoba man, Jeremy Bray, who has been fighting a degenerative disease, can breathe easier knowing his access to a crucial drug is now secured. After a federal agency reversed its stance against using the medication for adults over 25, the province has committed to covering the costs. This development is significant as it ensures that patients like Bray, who rely on this drug to slow disease progression, won't face disruptions in their treatment. The shift highlights the importance of ongoing policy reviews to ensure life-sustaining treatments remain accessible.